Ceruloplasmin Regulates Iron Levels in the CNS and Prevents Free Radical Injury

Ceruloplasmin is a ferroxidase that oxidizes toxic ferrous iron to its nontoxic ferric form. We have previously reported that a glycosylphosphatidylinositol-anchored form of ceruloplasmin is expressed in the mammalian CNS. To better understand the role of ceruloplasmin in iron homeostasis in the CNS, we generated a ceruloplasmin gene-deficient (Cp−/−) mouse. AdultCp−/− mice showed increased iron deposition in several regions of the CNS such as the cerebellum and brainstem. Increased lipid peroxidation was also seen in some CNS regions. Cerebellar cells from neonatalCp−/− mice were also more susceptible to oxidative stress in vitro.Cp−/− mice showed deficits in motor coordination that were associated with a loss of brainstem dopaminergic neurons. These results indicate that ceruloplasmin plays an important role in maintaining iron homeostasis in the CNS and in protecting the CNS from iron-mediated free radical injury. Therefore, the antioxidant effects of ceruloplasmin could have important implications for various neurodegenerative diseases such as Parkinson's disease and Alzheimer's disease in which iron deposition is known to occur.

[1]  J. Gitlin,et al.  Biochemical Analysis of a Missense Mutation in Aceruloplasminemia* , 2002, The Journal of Biological Chemistry.

[2]  C. Vulpe,et al.  Cloning and gastrointestinal expression of rat hephaestin: relationship to other iron transport proteins. , 2001, American journal of physiology. Gastrointestinal and liver physiology.

[3]  J. Connor,et al.  Iron deficiency alters H- and L-ferritin expression in rat brain. , 2000, Cellular and molecular biology.

[4]  M. A. Wilson,et al.  Regulation and developmental expression of the divalent metal-ion transporter in the rat brain. , 2000, Cellular and molecular biology.

[5]  P. Caroni,et al.  Early and Selective Loss of Neuromuscular Synapse Subtypes with Low Sprouting Competence in Motoneuron Diseases , 2000, The Journal of Neuroscience.

[6]  S. Ousman,et al.  Lysophosphatidylcholine induces rapid recruitment and activation of macrophages in the adult mouse spinal cord , 2000, Glia.

[7]  A. Brownlie,et al.  Positional cloning of zebrafish ferroportin1 identifies a conserved vertebrate iron exporter , 2000, Nature.

[8]  S. David,et al.  Alternative RNA Splicing Generates a Glycosylphosphatidylinositol-anchored Form of Ceruloplasmin in Mammalian Brain* , 2000, The Journal of Biological Chemistry.

[9]  S. Choi,et al.  Fragmentation of human ceruloplasmin induced by hydrogen peroxide. , 2000, Biochimie.

[10]  R J Simpson,et al.  A novel duodenal iron-regulated transporter, IREG1, implicated in the basolateral transfer of iron to the circulation. , 2000, Molecular cell.

[11]  D. Richardson Role of ceruloplasmin and ascorbate in cellular iron release. , 1999, The Journal of laboratory and clinical medicine.

[12]  N. Andrews The iron transporter DMT1. , 1999, The international journal of biochemistry & cell biology.

[13]  J. Gitlin,et al.  Targeted gene disruption reveals an essential role for ceruloplasmin in cellular iron efflux. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[14]  C. Ríos,et al.  Reduced ferroxidase activity in the cerebrospinal fluid from patients with Parkinson's disease , 1999, Neuroscience Letters.

[15]  J. Connor,et al.  Existing and emerging mechanisms for transport of iron and manganese to the brain , 1999, Journal of neuroscience research.

[16]  J. Connor,et al.  Changes in iron histochemistry after hypoxic‐ischemic brain injury in the neonatal rat , 1999, Journal of neuroscience research.

[17]  Gregory J. Anderson,et al.  Hephaestin, a ceruloplasmin homologue implicated in intestinal iron transport, is defective in the sla mouse , 1999, Nature Genetics.

[18]  M. Mauk,et al.  Using Genetic Mutations to Study the Neural Basis of Behavior , 1998, Cell.

[19]  Steven H. Strogatz,et al.  Cellular Construction of a Circadian Clock: Period Determination in the Suprachiasmatic Nuclei , 1997, Cell.

[20]  A. Bowie,et al.  Lipid Peroxidation Is Involved in the Activation of NF-κB by Tumor Necrosis Factor but Not Interleukin-1 in the Human Endothelial Cell Line ECV304 , 1997, The Journal of Biological Chemistry.

[21]  G. Perry,et al.  Iron accumulation in Alzheimer disease is a source of redox-generated free radicals. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[22]  B. N. Patel,et al.  A Novel Glycosylphosphatidylinositol-anchored Form of Ceruloplasmin Is Expressed by Mammalian Astrocytes* , 1997, The Journal of Biological Chemistry.

[23]  S. Young,et al.  Ceruloplasmin, transferrin and apotransferrin facilitate iron release from human liver cells , 1997, FEBS letters.

[24]  J. Gitlin,et al.  Expression of the ceruloplasmin gene in the human retina and brain: implications for a pathogenic model in aceruloplasminemia. , 1996, Human molecular genetics.

[25]  J. Gitlin,et al.  Ceruloplasmin gene expression in the murine central nervous system. , 1996, The Journal of clinical investigation.

[26]  W. Slikker,et al.  Age-related changes in antioxidant enzymes, superoxide dismutase, catalase, glutathione peroxidase and glutathione in different regions of mouse brain , 1995, International Journal of Developmental Neuroscience.

[27]  C. Winterbourn Toxicity of iron and hydrogen peroxide: the Fenton reaction. , 1995, Toxicology letters.

[28]  H. Morita,et al.  Hereditary ceruloplasmin deficiency with hemosiderosis: A clinicopathological study of a japanese family , 1995, Annals of neurology.

[29]  R. MacGillivray,et al.  Aceruloplasminemia: molecular characterization of this disorder of iron metabolism. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[30]  Akinori Nakamura,et al.  A mutation in the ceruloplasmin gene is associated with systemic hemosiderosis in humans , 1995, Nature Genetics.

[31]  L. Phebus,et al.  Measurement of striatal H2O2 by microdialysis following global forebrain ischemia and reperfusion in the rat: correlation with the cytotoxic potential of H2O2 in vitro , 1995, Brain Research.

[32]  P. Riederer,et al.  Altered Brain Metabolism of Iron as a Cause of Neurodegenerative Diseases? , 1994, Journal of neurochemistry.

[33]  S. David,et al.  A Monoclonal Antibody That Recognizes an Adhesion Molecule Expressed by Certain Cells of Neuroectodermal and Mesenchymal Origin , 1994, Molecular and Cellular Neuroscience.

[34]  C. Olanow A radical hypothesis for neurodegeneration , 1993, Trends in Neurosciences.

[35]  J. Connor,et al.  Ceruloplasmin levels in the human superior temporal gyrus in aging and Alzheimer's disease , 1993, Neuroscience Letters.

[36]  K. Zahs,et al.  Characterization of “plasma proteins” secreted by cultured rat macroglial cells , 1993, Glia.

[37]  J. Connor,et al.  Transferrin receptor expression in myelin deficient (md)rats , 1992, Journal of neuroscience research.

[38]  J. Gitlin,et al.  Primary structure of rat ceruloplasmin and analysis of tissue-specific gene expression during development. , 1990, The Journal of biological chemistry.

[39]  M. Hansen,et al.  Re-examination and further development of a precise and rapid dye method for measuring cell growth/cell kill. , 1989, Journal of immunological methods.

[40]  H. Miyajima,et al.  Familial apoceruloplasmin deficiency associated with blepharospasm and retinal degeneration , 1987, Neurology.

[41]  E. Frieden,et al.  The possible significance of the ferrous oxidase activity of ceruloplasmin in normal human serum. , 1966, The Journal of biological chemistry.

[42]  L. Levin,et al.  Expression of ceruloplasmin in the retina: induction after optic nerve crush. , 1998, Investigative ophthalmology & visual science.

[43]  J. Kaplan,et al.  Molecular mechanisms of iron uptake in eukaryotes. , 1996, Physiological reviews.

[44]  Alexandra L. Joyner,et al.  Gene targeting: a practical approach. , 1993 .

[45]  J. Gutteridge,et al.  Iron and oxygen radicals in brain , 1992, Annals of neurology.

[46]  K. Schaich,et al.  Prooxidant action of desferrioxamine: Fenton-like production of hydroxyl radicals by reduced ferrioxamine. , 1986, Journal of free radicals in biology & medicine.

[47]  J. Torrance Tissue iron stores , 1980 .